NCT01858740 · OUTCOME

Transplant Related Mortality

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children · Source last updated 2024-03-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: COUNT_OF_PARTICIPANTS
Unit: Participants
Interval / dispersion: Not reported
Time frame: Up to 5 years

What was measured

Transplant related mortality defined as mortality in any patient for whom there has not been a diagnosis of relapse

Groups in this outcome

Overall Study Participants

All participants in single arm study received CD45RA+ T cell depletion PBSC transplant and IV Methotrexate and tacrolimus for GVHD prophylaxis

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Overall Study Participants	20

Reported measurements

Source class 1

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Overall Study Participants	3	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
3

denoms

counts
group Id
OG000
value
20
units
Participants

description

Transplant related mortality defined as mortality in any patient for whom there has not been a diagnosis of relapse

groups

description
All participants in single arm study received CD45RA+ T cell depletion PBSC transplant and IV Methotrexate and tacrolimus for GVHD prophylaxis
id
OG000
title
Overall Study Participants

param Type

COUNT_OF_PARTICIPANTS

reporting Status

POSTED

time Frame

Up to 5 years

title

Transplant Related Mortality

type

SECONDARY

unit Of Measure

Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice